NEW YORK, NY--(Marketwired - April 27, 2017) - Artemis Therapeutics, Inc. (OTC PINK: ATMS), ("Artemis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...
Immunologic Response and Pathogenic Mechanisms of Cytomegalovirus Infection in Transplant Recipients
Immunity mechanisms of cytomegalovirus infection control have been studied recently and have contributed to the better understanding of the pathogenesis of this disease in patients with a solid organ ...
Cytomegalovirus (CMV) infection remains a common complication after allogeneic hematopoietic-cell transplantation. Letermovir is an antiviral drug that inhibits the CMV–terminase complex. In this ...
Cytomegalovirus (CMV) is a herpes virus. Infection can cause flu-like symptoms, although it is often symptomless. In people with weakened immune systems, it can reactivate and affect the eyes, lungs, ...
Cytomegalovirus (CMV) is a common virus. According to the Centers for Disease Control and Prevention (CDC), it infects between 50 to 80 percent of all adults by the time they reach 40 years old.
Cytomegalovirus (CMV) belongs to the herpes virus family. Infection with CMV is very common. Between 50% and 80% of people in the United States have had a CMV infection by the time they are 40 years ...
Cytomegalovirus, or CMV, is a common infection in both adults and children. Clinical trials for several vaccines are currently underway to help prevent people from developing CMV. The Centers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results